Startup Profile: Eyetamins (011)

Episode 11 July 18, 2021 00:23:48
Startup Profile: Eyetamins (011)
Innovation4Alpha
Startup Profile: Eyetamins (011)

Jul 18 2021 | 00:23:48

/

Show Notes

Eyetamins is a healthcare technology and life sciences company focused on therapeutics and consumer innovations in the $200B eye health and wellness space. They launched the company with natural supplements for eye health, which is a $37B industry. They have a patent-pending formula for dry eye, which is an $8B untapped market.

Other Episodes

Episode 33

September 10, 2022 00:19:37
Episode Cover

NXgenPort: Advancing remote care of cancer patients requiring a port (233)

NXgenPort (NGP), has designed an innovative and transformative technology to maximize remote care in cancer patients requiring an implantable chemo-port catheter. Combining proven chemo-port...

Listen

Episode 20

May 31, 2022 00:31:04
Episode Cover

Neobe: Battling Cancer With Safe Bacteria (220)

Neobe Therapeutics is an early-stage startup engineering safe recombinant bacterial products to enable immune infiltration in solid tumors. Their bacterial products combine innate tumor...

Listen

Episode 21

September 26, 2021 00:33:34
Episode Cover

Matt Patsky, CEO of Trillium Asset Management (021)

Matt Patsky is CEO and Lead Portfolio Manager of the Trillium ESG Global Equity strategy and Portfolio Manager of the Trillium Sustainable Opportunities strategy....

Listen